BIV's coverage delves into all issues affecting tech businesses in Vancouver and British Columbia

Securities regulator grapples with fintech innovations

Complications arise when new finance technology meets current securities regulations

How vaccine distribution is taking shape amid manufacturing hiccups, remote deliveries

Ottawa says Canada still set to receive four million doses by March even as Pfizer faces production issues

Rogers rolls out first 5G standalone core in Vancouver, expands B.C. coverage

Rogers Communications Inc. (TSX:RCI.B) is rolling out the first 5G standalone core in Canada, with Vancouver among four cities that will be able to eventually tap into the new infrastructure. The...

From keeping cool to prioritizing people, how B.C. businesses are supporting vaccine rollout

B.C. companies are stepping up to assist with the rollout of the vaccine

AbCellera’s market value hits US$15.7b after first day of trading

Vancouver biotech known for its work on a COVID-19 treatment

Beware – Santa could bring home cybersecurity risks

Proliferation of home high-tech gadgets could expose personal data to crooks

AbCellera boosts IPO target second time in a week, seeks to raise US$483m

The B.C. biotech firm instrumental in the development of a COVID-19 treatment has boosted its ambitions for an initial public offering for the second time in a week. AbCellera Biologics Inc....

Boast.AI raises $30m as B.C. tech firm hones in on R&D tax credits for others

Vancouver company plans to boost its headcount following close of Series A funding round

B.C. biotech in the spotlight after Health Canada approves Pfizer-BioNTech vaccine

Vancouver-based Acuitas Therapeutics played key role in vaccine's development